Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Heart, Vascular and Thoracic

physician watching monitor screens during an electrophysiology procedure

Pulsed Field Ablation: Current State and Where It’s Heading

As use for atrial arrhythmias surges, studies turn to ventricular arrhythmias

surgical team working at the operating table in an operating room

Multicenter Trial Launched to Evaluate New LVAD Option for Advanced Heart Failure

Staged pivotal noninferiority study is comparing BrioVAD with HeartMate 3

LDL cholesterol particles floating in bloodstream

Obicetrapib-Ezetimibe Combo Therapy Halves LDL Cholesterol Levels Relative to Placebo

Phase 3 TANDEM study may help pave way to first approval of a CETP inhibitor

lipoprotein(a) particle

Large Cohort Study Reveals Vanishingly Small Rates of Lipoprotein(a) Testing

Yet 21.4% of tested individuals had Lp(a) elevation

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

older woman jogging outside

Lessons From TRIM-AF: Novel Trial Raises Profile of Lifestyle Changes in Atrial Fibrillation

While results were negative for metformin, lifestyle counseling showed surprising promise

surgical team during a heart operation

AATS Quality Gateway: Comprehensive and Nuanced Cardiac Surgery Risk Modeling Is at Hand

Launch of the tool promises to reshape quality assessment across the specialty

doctor looking at a patient in a hospital bed

Defining the Role and Needs of the Modern Cardiac ICU

AHA scientific statement outlines models for high-intensity staffing, specialized expertise and more

electrocardiogram tracing

AI-Enhanced ECG Analysis Shows Strong Accuracy in Detecting Hypertrophic Cardiomyopathy

5% of flagged ECGs in real-world study were from patients with previously undiagnosed HCM

Lp(a) particles floating among red blood cells

Lepodisiran’s Large, Durable Lp(a) Reductions in Phase 2 Trial Boost Anticipation of Phase 3 Results

Small interfering RNA lowered lipoprotein(a) by 94% during six-month follow-up after a single dose

blood pressure cuff on a woman's arm

Lorundrostat Shows Continued Promise Against Uncontrolled Hypertension

Phase 2b trial of aldosterone synthase inhibitor also finds no benefit from dose escalation

BackPage 1 of 82Next

Advertisement

Ad